ATE331739T1 - Polyanionische polymere mit verbesserter fusogenfähigkeit - Google Patents

Polyanionische polymere mit verbesserter fusogenfähigkeit

Info

Publication number
ATE331739T1
ATE331739T1 AT99920057T AT99920057T ATE331739T1 AT E331739 T1 ATE331739 T1 AT E331739T1 AT 99920057 T AT99920057 T AT 99920057T AT 99920057 T AT99920057 T AT 99920057T AT E331739 T1 ATE331739 T1 AT E331739T1
Authority
AT
Austria
Prior art keywords
fusogen
capacity
improved
peaa
lipo
Prior art date
Application number
AT99920057T
Other languages
English (en)
Inventor
Tao Chen
Yuehua He
Peter Cullis
Thomas Madden
Peter Scherrer
Jung Soo Kim
David Tirrell
Phalgun Joshi
Original Assignee
Inex Pharmaceuticals Corp
Tao Chen
Yuehua He
Peter Cullis
Thomas Madden
Peter Scherrer
Jung Soo Kim
David Tirrell
Phalgun Joshi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inex Pharmaceuticals Corp, Tao Chen, Yuehua He, Peter Cullis, Thomas Madden, Peter Scherrer, Jung Soo Kim, David Tirrell, Phalgun Joshi filed Critical Inex Pharmaceuticals Corp
Application granted granted Critical
Publication of ATE331739T1 publication Critical patent/ATE331739T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes or liposomes coated or grafted with polymers
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/12—Hydrolysis
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F8/00—Chemical modification by after-treatment
    • C08F8/30—Introducing nitrogen atoms or nitrogen-containing groups
    • C08F8/32—Introducing nitrogen atoms or nitrogen-containing groups by reaction with amines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
AT99920057T 1998-04-28 1999-04-27 Polyanionische polymere mit verbesserter fusogenfähigkeit ATE331739T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8329498P 1998-04-28 1998-04-28

Publications (1)

Publication Number Publication Date
ATE331739T1 true ATE331739T1 (de) 2006-07-15

Family

ID=22177405

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99920057T ATE331739T1 (de) 1998-04-28 1999-04-27 Polyanionische polymere mit verbesserter fusogenfähigkeit

Country Status (5)

Country Link
EP (1) EP1100834B1 (de)
AT (1) ATE331739T1 (de)
AU (1) AU3764099A (de)
DE (1) DE69932164D1 (de)
WO (1) WO1999055743A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6727230B1 (en) 1994-03-25 2004-04-27 Coley Pharmaceutical Group, Inc. Immune stimulation by phosphorothioate oligonucleotide analogs
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
SI1077722T1 (sl) 1998-05-22 2007-02-28 Ottawa Health Research Inst Metode in produkti za induciranje sluznicne imunosti
DE60008234T2 (de) * 1999-04-29 2004-12-30 Alza Corp., Mountain View Liposomenzusammensetzungen zur verbesserten wirkstoffzurückhaltung
EP1320553A4 (de) * 2000-08-23 2006-03-15 Phairson Medical Inc Neue polymerzusammensetzung
JP4361789B2 (ja) 2001-08-14 2009-11-11 ヴァルダーム・アンパルトセルスカブ 体表の過剰増殖疾患の処置
CA2502015A1 (en) 2002-12-11 2004-06-24 Coley Pharmaceutical Group, Inc. 5' cpg nucleic acids and methods of use
US12297285B2 (en) 2022-06-24 2025-05-13 Orna Therapeutics, Inc. Circular RNA encoding chimeric antigen receptors targeting BCMA

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4118554A (en) * 1977-07-25 1978-10-03 Monsanto Company Aggregated polyelectrolytes
US5149543A (en) * 1990-10-05 1992-09-22 Massachusetts Institute Of Technology Ionically cross-linked polymeric microcapsules
EP0554407A1 (de) * 1990-10-26 1993-08-11 Genta Incorporated Nichtaromatische organische polymerreagentien für die festphasensynthese von oligomeren
US5180782A (en) * 1991-02-19 1993-01-19 Basf Corporation Compatible polyamide-acrylic compositions
JP3708567B2 (ja) * 1994-07-20 2005-10-19 日清紡績株式会社 生物学的に活性な物質を固定するための方法

Also Published As

Publication number Publication date
EP1100834B1 (de) 2006-06-28
WO1999055743A9 (en) 2000-10-05
AU3764099A (en) 1999-11-16
DE69932164D1 (de) 2006-08-10
EP1100834A1 (de) 2001-05-23
WO1999055743A1 (en) 1999-11-04

Similar Documents

Publication Publication Date Title
Nishimura et al. Substrate-sorting nanoreactors based on permeable peptide polymer vesicles and hybrid liposomes with synthetic macromolecular channels
Miyata et al. Rational design of smart supramolecular assemblies for gene delivery: chemical challenges in the creation of artificial viruses
Wang et al. Prodrug approaches to the improved delivery of peptide drugs
YU44404A (sh) Postupak za identifikovanje ciljnih enzima tumora
CY1107711T1 (el) Υπογλωσσια χορηγηση φαρμακευτικης συνθεσης ως αγωγη εναντι οξεων διαταραχων
Yazdi et al. In vivo endothelial cell gene silencing by siRNA‐LNPs tuned with lipoamino bundle chemical and ligand targeting
AP1760A (en) Platinum derivative pharmaceutical formulations.
BR0010648A (pt) Utilização de microesferas biodegradáveis que liberam um agente anticanceroso radiossensibilizador, processo de preparação de microesferas biodegradáveis, e, suspensão constituìda de uma solução estéril
ES2156581T1 (es) Aplicaciones terapeuticas y diagnosticas basadas en el papel del gen cxcr-4 en tumorogenesis.
NZ501950A (en) Medicinal compositions for application to mucosa
ATE331739T1 (de) Polyanionische polymere mit verbesserter fusogenfähigkeit
WO2003099225A3 (en) Compositions for delivering nucleic acids to cells
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
TR200201089T2 (tr) Dipiridamol veya mopidamolün fibrine bağlı mikrodolaşım bozukluklarının tedavisi
IT1314185B1 (it) Composizione farmaceutica per somministrazione di sostanze attivescarsamente solubili in mezzi acquosi
DE69830249D1 (de) Zielgerichtete liposomen zur verabreichung von genen
WO1998000541A3 (en) Methods for administration of recombinant gene delivery vehicles for treatment of human disease
WO2001013933A3 (en) Agents for the enhanced oxygen delivery in mammals
YU68702A (sh) Novi lhrh-antagonisti, njihova proizvodnja i upotreba kao leka
Dreaden et al. RNA‐peptide nanoplexes drug DNA damage pathways in high‐grade serous ovarian tumors
ATE226065T1 (de) Feste instant-release-darreichungsformen und verfahren zu ihrer herstellung
WO2001041747A3 (de) Pharmazeutische zubeteitung enthaltend zytostatika und electronenakzeptoren zur behandlung von krebs
WO2001068676A3 (de) Lh-rh-antagonisten, deren herstellung und verwendung als arzeimittel
WO2023164034A3 (en) Dnase enzymes engineered for improved stability
WO2000017375A3 (en) Method to treat haemophilia by in vivo gene therapy with retroviral vectors

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties